FDA Inspection 956160 — Granules India Limited
The FDA completed an inspection of Granules India Limited on December 18, 2015 in Visakhapatnam. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 18, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Visakhapatnam (India)